The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...
Want a say in the news? Email Claudia at
[email protected] to have your thoughts on the stories covered here or on PennLive heard. You can listen to the latest episode of “Today in Pa” on any of ...
These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.